Role of defensins in innate immunity
Abstract
Immune system of living organisms ranging from fungi, plants, vertebrates and invertebrates are all aided by polypeptide chains like defensins and cathelicidins. In humans the defensisns are quite fundamental part of innate immune system in combating with day-to-day exposure to unknown pathogens. The defensins are classified as alpha beta and sigma defensins expressed at chromosome 8 at nearly same positions, the sigma defensin is however synthetically developed as reterocyclin, as it has been stopped producing because of evolutionary development of stop codon 7.5 million years ago. The expression of Defensins can be either constitutive or inducible through epithelial cells, Paneth cells or other respective immune cells to regulate the activation of the innate immune responses. These impart their role either by direct microbicidal action, antiviral activity, inactivation or neutralization of microbial products, mobilization or activation of phagocytes and mast cells. Further to this there is lot more to explore about the availability of similar genetic expressions as defensins with unclear functions and in vivo experimental models development.
Downloads
References
Prasad SV, Fiedoruk K, Daniluk T, Piktel E, Bucki R. Expression and Function of Host Defense Peptides at Inflammation Sites. Int J Mol Sci. 2019; 21(1):104.
DOI: https://doi.org/10.3390/ijms21010104.
Machado LR, Ottolini B. An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses. Front Immunol. 2015; 6:115.
DOI: https://doi.org/10.3389/fimmu.2015.00115
Ganz T, Lehrer RI. Defensins. Pharmacol Ther. 1995; 66(2):191-205.
DOI: https://doi.org/10.1016/01637258(94)00076-F
Wilde CG, Griffith JE, Marra MN, Snable JL, Scott RW. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem. 1989; 264(19):11200-3.
DOI: https://doi.org/10.1016/S00219258(18)60449-1
Selsted ME, Harwig SS. Determination of the disulfide array in the human defensin HNP-2: a covalently cyclized peptide. J Biol Chem. 1989; 264(7):4003-7.
DOI: https://doi.org/10.1016/S00219258(19)84952-9
Hill CP, Yee J, Selsted ME, Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science. 1991; 251(5000):1481-5.
DOI: https://doi.org/10.1126/science.2006422
Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003; 3(9):710-20.
Bensch KW, Raida M, Mägert HJ, Schulz-Knappe P, Forssmann WG. hBD‐1: a novel β‐defensin from human plasma. FEBS letters. 1995; 368(2):331-5.
DOI: https://doi.org/10.1016/0014-5793(95)00687-5
Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Curr Pharm Des. 2007; 13(30):3131-9.
DOI: https://doi.org/10.2174/138161207782110453.
Cole AM, Hong T, Boo LM, Nguyen T, Zhao C, Bristol G, et al. Retrocyclin: a primate peptide that protects cells from infection by T-and M-tropic strains of HIV-1. Proc Natl Acad Sci. 2002; 99(4):1813-8.
DOI: https://doi.org/10.1073/pnas.052706399
Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol. 2004; 22:181-215.
DOI: https://doi.org/10.1146/annurev.immunol.22.012703.104603
Prasad SV, Fiedoruk K, Daniluk T, Piktel E, Bucki R. Expression and Function of Host Defense Peptides at Inflammation Sites. Int J Mol Sci. 2019; 21(1):104.
DOI: https://doi.org/10.3390/ijms21010104.
Hazlett L, Wu M. Defensins in innate immunity. Cell Tissue Res. 2011; 343(1):175-88.
DOI: https://doi.org/10.1007/s00441-010-1022-4.
Xu D, Lu W. Defensins: A Double-Edged Sword in Host Immunity. Front Immunol. 2020; 11:764.
DOI: https://doi.org/10.3389/fimmu.2020.00764.
Kim C, Gajendran N, Mittrucker HW, Weiwad M, Song YH, Hur- witz R, et al. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci USA 2005; 102: 4830-5.
DOI: https://doi.org/10.1073/pnas.0500508102
Scott MG, Vreugdenhil AC, Buurman WA, Hancock REW. Cut- ting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 2000; 164(2):549-53.
DOI: https://doi.org/10.4049/jimmunol.164.2.549
Motzkus D, Schulz-Maronde S, Heitland A, Schulz A, Forssmann WG, Jübner M, et al. The novel β‐defensin DEFB123 prevents lipopolysaccharide‐mediated effects in vitro and in vivo. The FASEB J. 2006; 20(10):1701-2.
DOI: https://doi.org/10.1096/fj.05-4970fje
Allaker RP. Host defence peptides—a bridge between the innate and adaptive immune responses. Trans R Soc Trop Med Hyg. 2008; 102(1):3-4.
DOI: https://doi.org/10.1016/j.trstmh.2007.07.005.
van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS. Neutrophil defensins stimulate the release of cytoki- nes by airway epithelial cells: modulation by dexamethasone. In- flamm Res 2002; 51: 8-15.
Yamaguchi Y, Nagase T, Mikita R, Fukuhara S, Tomita T, Tomi- naga T, et al. Identification of multiple novel epididymis-specific -defensin isoforms in humans and mice. J Immunol 2002; 169(5):2516-23.
DOI: https://doi.org/10.4049/jimmunol.169.5.2516
Yang D, Liu ZH, Tewary P, Chen Q, De la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Curr Pharm Des. 2007; 13(30):3131-9.
DOI: https://doi.org/10.2174/138161207782110453
Sau S, Sun J, Lee CY. Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J Bacteriol. 1997; 179(5):1614-21.
DOI: https://doi.org/10.1128/jb.179.5.1614-1621.1997.
Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis. 2003; 62(suppl 2):ii17-21.
Copyright (c) 2021 Journal of Shifa Tameer-e-Millat University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Shifa Tameer-e-Millat University (JSTMU) is the owner of all copyright to any work published in the journal. Any material printed in JSTMU may not be reproduced without the permission of the editors or publisher. The Journal accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing and/or decision in this journal. The Editorial Board makes every effort to ensure the accuracy and authenticity of material printed in the journal. However, conclusions and statements expressed are views of the authors and do not necessarily reflect the opinions of the Editorial Board or JSTMU.
Content of this journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.